Healthcare -
Biotechnology - NASDAQ - US
$ 1.2
3.45 %
$ 49.3 M
Market Cap
-4.14
P/E
ANEB - TOTAL CURRENT LIABILITIES
Total Current Liabilities ANEB - Anebulo Pharmaceuticals, Inc.
261 K
LAST VALUE
-28.70%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR